{"id":"https://openalex.org/W2024968138","doi":"https://doi.org/10.1002/jps.2600510118","title":"New Alkaline-Stable Species for Selected Members of the Tetracycline Family","display_name":"New Alkaline-Stable Species for Selected Members of the Tetracycline Family","publication_year":1962,"publication_date":"1962-01-01","ids":{"openalex":"https://openalex.org/W2024968138","doi":"https://doi.org/10.1002/jps.2600510118","mag":"2024968138","pmid":"https://pubmed.ncbi.nlm.nih.gov/14491416"},"language":"en","primary_location":{"id":"doi:10.1002/jps.2600510118","doi":"https://doi.org/10.1002/jps.2600510118","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.2600510118","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049879404","display_name":"Edward G. Remmers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward G. Remmers","raw_affiliation_strings":["Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000327268","display_name":"George M. Sieger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George M. Sieger","raw_affiliation_strings":["Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111790914","display_name":"Albert P. Doerschuk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Albert P. Doerschuk","raw_affiliation_strings":["Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032947525","display_name":"Lawrence Ritter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Ritter","raw_affiliation_strings":["Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033420776","display_name":"Joseph F. Weidenheimer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph F. Weidenheimer","raw_affiliation_strings":["Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Product Development Laboratory, Lederle Laboratories Division, American Cyanamid Co., Pearl River, N. Y","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23021148,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"51","issue":"1","first_page":"86","last_page":"87"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.4832000136375427,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.4832000136375427,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.07169999927282333,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.02879999950528145,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tetracycline","display_name":"tetracycline","score":0.9409999847412109},{"id":"https://openalex.org/keywords/alkaline-stability","display_name":"alkaline stability","score":0.9549999833106995},{"id":"https://openalex.org/keywords/tetracycline-derivatives","display_name":"tetracycline derivatives","score":0.7099999785423279},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C2780923616","wikidata":"https://www.wikidata.org/wiki/Q193045","display_name":"Tetracycline","level":3,"score":0.7669442296028137},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5412582159042358},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23451945185661316},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.16353556513786316}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013752","descriptor_name":"Tetracycline","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/jps.2600510118","doi":"https://doi.org/10.1002/jps.2600510118","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.2600510118","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:14491416","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14491416","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2324805309"],"related_works":["https://openalex.org/W2045193873","https://openalex.org/W1971414969","https://openalex.org/W4290657067","https://openalex.org/W2438705156","https://openalex.org/W4300807892","https://openalex.org/W2986463650","https://openalex.org/W2404706941","https://openalex.org/W2412749749","https://openalex.org/W2411549961","https://openalex.org/W2412680380"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}